CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Other Combination Anti-Cancer Therapies

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
RHHBYPhase 3

Pertuzumab Phase 3 Est. Readout

Other Combination Anti-Cancer Therapies
Dec 2026~
CT.gov
00%
Competitive Landscape

1 competitor in Solid Tumors

View Full Landscape
Drug Information

Target Indication

Solid Tumors

Clinical Trial

NCT02320435

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.